PDGFRA mutations are frequently observed in patients with gastrointestinal stromal tumors (GIST; 5–10%)4, non-small cell lung cancer (6%, TCGA), and colorectal cancer (5%, TCGA). Here, PDGFRA is linked to gastrointestinal stromal tumor.